Who We Are
Ipsen US is comprised of both Ipsen Biopharmaceuticals, Inc. and Ipsen Bioscience, Inc. At Ipsen, we have a clear mission: to improve patients’ lives. We are a dynamic and growing global biopharmaceutical leader focused on innovation and specialty care, with a focus on 3 core areas: oncology, neuroscience, and rare diseases.
The patients we serve live with serious and rare diseases, and we pride ourselves on putting these patients first. It’s this approach to our daily work that has led Ipsen to make the bold ambition of launching at least 1 new product or meaningful indication each year.
To keep this ambition, we work with a sense of urgency and the agility of a biotech—leveraging our global reach—to bring innovative products to the patients who need them most.
Who We Are
To fuel and accelerate our rapid growth, we have expanded our presence in the leading biotech ecosystem and established our North American headquarters in Cambridge, Massachusetts, where we have a global hub and a fully integrated biopharmaceutical team collaborating across US and global commercial operations, Global External Innovation and Partnering, R&D, and manufacturing.
We have strategically expanded our footprint in Cambridge so we can be in the heart of the leading global biotech ecosystem.
Our Cambridge Leadership Team
Richard Paulson, Executive Vice President and CEO of Ipsen North America
Howard Mayer, MD, Executive Vice President, R&D, and Chief Scientific Officer
John Kehoe, Vice President, Ipsen Cambridge Manufacturing, US
Read more about the strong international experience of Ipsen’s global leadership team.
Our people—the foundation on which we achieve the Ipsen Group’s mission and success—are driven by a passion to win for patients and bring this mission to life every day. We are always ready to listen to—and learn from—patients. Every day, our more than 5,400 employees worldwide, approximately 600 of whom are in North America, work diligently with the singular purpose of developing and commercializing innovative medicines to improve the lives of patients around the world with difficult-to-treat diseases.
Ipsen North American Leadership Team
Executive Vice President and CEO, Ipsen NA
Vice President, Head of New Products & Innovation
Senior Vice President, Franchise Head, Oncology Business Unit
Vice President, Franchise Head, Neuroscience Business Unit
Senior Vice President and NA General Counsel, Legal Affairs
Senior Vice President and Business Unit Head, Rare Disease – NA
Senior Vice President, NA, HR & Global Talent Acquisition
General Manager, Ipsen Canada
Vice President, NA Government Affairs & Public Policy
Vice President, Ethics & Compliance, NA
Vice President, Value and Access
Vice President, Business Operations
Vice President, Communications and Patient Advocacy
Senior Vice President, CFO, Ipsen NA
Chief of Staff and Strategic Initiatives
Any statements contained in this website that do not describe historical facts are forward-looking statements that involve risks and uncertainties that could cause actual results to differ materially. Ipsen cautions users not to place undue reliance on any forward-looking statements. Ipsen disclaims any obligation to publicly update or revise any such statements to reflect any changes on which any such statements may be based, or that may affect the likelihood that actual results will differ from those set forth in the forward-looking statements.